Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
3.590
-0.040 (-1.10%)
At close: Oct 30, 2026, 4:00 PM EDT
3.630
+0.040 (1.11%)
After-hours: Oct 30, 2026, 7:51 PM EDT

Wave Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
70.9242.73108.3113.313.6540.96
Revenue Growth
-35.07%-60.55%-4.42%3005.10%-91.09%104.03%
Gross Profit
-134.47-140.05-51.38-16.7-112.21-80.91
Operating Income
-227.61-215.38-110.4-68-162.72-127.02
Net Income
-210.53-204.38-97.01-57.51-161.82-122.25
Earnings Per Share
-1.07-1.21-0.70-0.54-2.05-2.36
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
431.01602.07302.08200.3588.5150.56
Total Debt
43.2717.7725.432.1237.6129.92
Net Cash (Debt)
387.74584.3276.67168.2350.88120.65
Net Cash Growth
119.75%111.19%64.46%230.63%-57.83%-22.26%
Net Cash Per Share
1.973.462.001.590.652.33

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-207.05-187.49-151.03-19.43-127.78-88.99
Capital Expenditures
-1.34-0.72-0.94-1.12-1.36-0.56
Free Cash Flow
-208.39-188.21-151.96-20.55-129.14-89.55
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-189.60%--47.44%-14.74%--197.52%
Operating Margin
-320.94%-504.09%-101.94%-60.01%-4459.30%-310.07%
Pretax Margin
-296.86%-478.33%-89.57%-51.36%-4416.06%-298.92%
Profit Margin
-296.86%-478.34%-89.57%-50.76%-4434.72%-298.42%
FCF Margin
-293.83%-440.50%-140.31%-18.13%-3539.11%-218.61%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.9872.8117.425.31166.724.51